pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset
Status: UNKNOWN
Conditions: ST-segment Elevation Myocardial Infarction (STEMI)
Interventions: PROCEDURE: Primary PCI|OTHER: Optimal medical therapy with primary PCI not performed
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Three Different Dietary Messages on Dietary Intake and Health in Families
Status: ACTIVE_NOT_RECRUITING
Conditions: Obesity
Interventions: BEHAVIORAL: Increase Fruits and Vegetables|BEHAVIORAL: Decrease Snack Foods|BEHAVIORAL: Increase Fruits and Vegetables and Decrease Snack Foods
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effects of Activity Based Therapy on Upper Limb Strength and Transfer in Spinal Cord Injury Patients
Status: COMPLETED
Conditions: Spinal Cord Injuries
Interventions: OTHER: Activity base therapy|OTHER: Strength training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pelvic Floor Muscle Training for Women With Myotonic Dystrophy
Status: ENROLLING_BY_INVITATION
Conditions: Myotonic Dystrophy Type 1|Urinary Incontinence
Interventions: BEHAVIORAL: Pelvic floor muscle training
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
Status: COMPLETED
Conditions: Colon Cancer|Gastric Cancer|Pancreas Cancer|Rectal Cancer|Cholangiocarcinoma|Small Bowel Cancer|Esophageal Cancer
Interventions: OTHER: patient engagement platform
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Impact Evaluation of Triggerise's Tiko Platform
Status: COMPLETED
Conditions: Contraception|Iron Deficiency Anemia of Pregnancy|Antenatal Care|Postnatal Care
Interventions: BEHAVIORAL: Tiko Platform Behavioural cum mHealth Intervention|OTHER: Standard of Care / Business as Usual
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Photobiomodulation in Palate Wounds: Somatosensorial Evaluation
Status: RECRUITING
Conditions: Surgical Wound
Interventions: OTHER: Photobiomodulation|OTHER: Protection with surgical dressing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
Status: COMPLETED
Conditions: Essential Tremor|Parkinson's Disease
Interventions: OTHER: DaTscan™ - Non-Caucasian Participants|OTHER: DaTscan™ - Caucasian Participants
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 1
Interventions: DEVICE: Use of Insulclock system, both Insulclock device and Insulclock 360 app.|DEVICE: Use of Insulclock system, both Insulclock device and Insulclock app on masked mode.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Status: ACTIVE_NOT_RECRUITING
Conditions: Diabetes Mellitus, Type 2|Hemodialysis|Obese
Interventions: DRUG: Liraglutide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants
Status: COMPLETED
Conditions: Healthy|Renal Insufficiency
Interventions: DRUG: Pirtobrutinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)
Status: COMPLETED
Conditions: Cardiovascular Risk Factor|Stress|Self Efficacy|Depressive Symptoms|Health Behavior
Interventions: BEHAVIORAL: B-SWELL: Midlife Black Women's Stress Reduction Wellness Program|BEHAVIORAL: WE: Wellness program for Midlife Black Women
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Multi-vitamins, HAART and HIV/AIDS in Uganda
Status: COMPLETED
Conditions: HIV/AIDS
Interventions: DIETARY_SUPPLEMENT: Multivitamin supplements B,C and E
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia
Status: TERMINATED
Conditions: Chemotherapy|Cancer|Anemia
Interventions: DRUG: epoetin alfa
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Acute Care for Elders (ACE) Program at OHSU Hospital
Status: UNKNOWN
Conditions: Delirium|Age-Related Cognitive Decline|Frail Elderly|Hospital Acquired Pressure Ulcer|Drug-Related Side Effects and Adverse Reactions
Interventions: OTHER: Acute Care of Elders focused geriatric care
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
Status: COMPLETED
Conditions: Dry Eye Disease
Interventions: DRUG: Azithromycin Ophthalmic Solution, 1%|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant
Status: COMPLETED
Conditions: Hernioplasty
Interventions: DRUG: 2 100mg Xaracoll implants|DRUG: 3 100mg Xaracoll implants|DRUG: 150mg Bupivacaine HCl injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
Status: COMPLETED
Conditions: Alzheimer's Disease
Interventions: DRUG: Bexarotene|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Treatment of Acute Lymphoblastic Leukemia in Children
Status: COMPLETED
Conditions: Acute Lymphoblastic Leukemia
Interventions: DRUG: prednisone|DRUG: dexamethasone|DRUG: doxorubicin|DRUG: E. coli asparaginase|DRUG: vincristine|DRUG: methotrexate|DRUG: Leucovorin|DRUG: Asparaginase|DRUG: cytarabine|DRUG: Methotrexate/Hydrocortisone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Status: COMPLETED
Conditions: Kidney Transplantation|Transplantation Immunology|Host vs Graft Reaction
Interventions: DRUG: Prograf-XL|DRUG: Prograf|DRUG: MMF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Status: COMPLETED
Conditions: Multiple Myeloma
Interventions: DRUG: Cyclophosphamide|DRUG: Etoposide|DRUG: Melphalan|DRUG: Carmustine|DRUG: Filgrastim
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase I/II Clinical Study of the KL003 Cell Injection in β-Thalassemia Major Participants
Status: NOT_YET_RECRUITING
Conditions: Transfusion-dependent Beta-Thalassemia
Interventions: DRUG: KL003 Cell Injection Drug Product
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Physical Activity Coaching in Patients With Post-COVID-19
Status: NOT_YET_RECRUITING
Conditions: Post-COVID-19 Syndrome
Interventions: BEHAVIORAL: Self-monitoring|BEHAVIORAL: Goal setting and review|BEHAVIORAL: Education|BEHAVIORAL: Feedback|BEHAVIORAL: Contact|BEHAVIORAL: Exercise|BEHAVIORAL: Report|BEHAVIORAL: Social support|BEHAVIORAL: Group activities|BEHAVIORAL: World Health Organization recommendations for being physically active
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
Status: COMPLETED
Conditions: Essential Hypertension
Interventions: DRUG: Irbesartan/Amlodipine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Status: TERMINATED
Conditions: Salivary Gland Squamous Cell Carcinoma|Stage II Salivary Gland Cancer|Stage II Squamous Cell Carcinoma of the Hypopharynx|Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage II Squamous Cell Carcinoma of the Oropharynx|Stage II Verrucous Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: RADIATION: intensity-modulated radiation therapy|DRUG: cisplatin|RADIATION: image-guided adaptive radiation therapy|OTHER: 3'-deoxy-3'-[18F]fluorothymidine|PROCEDURE: positron emission tomography/computed tomography|RADIATION: fludeoxyglucose F 18
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients
Status: UNKNOWN
Conditions: Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
Interventions: PROCEDURE: Autologous bone marrow mononuclear cell transplantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Status: COMPLETED
Conditions: Kidney Transplant|Type 1 Diabetes
Interventions: DRUG: Alpha 1-Antitrypsin|PROCEDURE: Islet Transplantation|DRUG: Thymoglobulin|DRUG: Basiliximab|DRUG: Etanercept
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Parental Support Intervention in the Oncological Context
Status: COMPLETED
Conditions: Parent-Child Relations|Parenting|Communication Programs
Interventions: BEHAVIORAL: Parental guidance
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Status: COMPLETED
Conditions: Childhood Acute Promyelocytic Leukemia
Interventions: DRUG: ATO|DRUG: RIF|DRUG: ATRA|DRUG: mitoxantrone|DRUG: Ara-C|DRUG: MTX|DRUG: 6MP|OTHER: intrathecal injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
Status: COMPLETED
Conditions: Prostatic Hyperplasia
Interventions: DRUG: Dutasteride (0.5mg)|DRUG: FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg)|DRUG: Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison Of Aesthetic Techniques For Rejuvenation Of Genital Region: A Randomized Clinical Trial
Status: RECRUITING
Conditions: Laxity; Skin|Skin Hyperpigmentation|Needlestick Puncture
Interventions: DEVICE: Comparison of aesthetic techniques
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
Status: COMPLETED
Conditions: Eosinophilic Esophagitis
Interventions: DRUG: Sucralfate|PROCEDURE: Intraluminal Impedance|DEVICE: Intraluminal Impedance
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in War Victims
Status: COMPLETED
Conditions: PTSD|Depression|Anxiety|Chronic Pain|Anger
Interventions: BEHAVIORAL: BF-CBT and group physiotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Does DHEA IVF Outcomes in Poor Responders?
Status: SUSPENDED
Conditions: Infertility, Female|Poor Response to Ovulation Induction
Interventions: DRUG: Dehydroepiandrosterone|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Optimal Treatment of MRSA Throat Carriers
Status: RECRUITING
Conditions: MRSA|MRSA Colonization
Interventions: DRUG: Clindamycin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
Status: COMPLETED
Conditions: Sunscreening Agent
Interventions: DRUG: BAY987517|DRUG: Sunscreen Lotion (RB# T78-190B)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
Status: COMPLETED
Conditions: Myocardial Infarction|Death
Interventions: PROCEDURE: Bone Marrow aspiration and intracoronary reinfusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors
Status: COMPLETED
Conditions: Soft Tissue Sarcoma|Lipoma|Tumor
Interventions: OTHER: Incisional negative pressure wound therapy|OTHER: Wound dressing with adhesive tapes
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder
Status: COMPLETED
Conditions: Borderline Personality Disorder|Alcohol Use Disorder
Interventions: BEHAVIORAL: Psychodynamic Therapy|BEHAVIORAL: Optimized Community Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Lung Atypical Carcinoid Tumor|Lung Neuroendocrine Neoplasm|Lung Non-Small Cell Squamous Carcinoma|Minimally Invasive Lung Adenocarcinoma|Neuroendocrine Carcinoma|Recurrent Lung Adenocarcinoma|Recurrent Lung Large Cell Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8
Interventions: BIOLOGICAL: Nivolumab|RADIATION: Stereotactic Body Radiation Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Perioperative Active Warming Techniques in Colorectal Surgeries
Status: TERMINATED
Conditions: Normothermia
Interventions: DEVICE: Group 1: VitaHeat|DEVICE: Group 2: Bair Hugger
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Investigating the Impact of Proactive Palliative Care
Status: ACTIVE_NOT_RECRUITING
Conditions: Metastatic Solid Tumor Cancers|Locally Advanced Solid Tumor Cancers
Interventions: BEHAVIORAL: Expectations Survey (CanCORS)|BEHAVIORAL: Values Survey (Serious Illness Care Program)|BEHAVIORAL: Functional Assessment of Cancer Therapy-General (FACT-G)|BEHAVIORAL: NCCN Distress Thermometer|BEHAVIORAL: Hospital Anxiety and Depression Scale (HADS)|BEHAVIORAL: Quality of Communication (QOC)|BEHAVIORAL: visits with a supportive care clinician
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Evaluation of Cognitive and Physical Training on MCI Elders
Status: NOT_YET_RECRUITING
Conditions: Cognitive Impairment|Mild Cognitive Impairment
Interventions: OTHER: Cognitive training|OTHER: Physical training|OTHER: Combined cognitive and physical training|OTHER: Passive information activities
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Improving Disease Severity
Status: ACTIVE_NOT_RECRUITING
Conditions: Psoriasis|Alopecia Areata|Polymorphous Light Eruption
Interventions: OTHER: Lumiton yarn sleeve|OTHER: Lumiton yarn hat|OTHER: Lumiton yarn shirt
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Status: WITHDRAWN
Conditions: Cervical Dysplasia
Interventions: DRUG: Nelfinavir
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib
Status: NOT_YET_RECRUITING
Conditions: Drug Kinetics
Interventions: DRUG: Radotinib HCl
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: Baricitinib|DRUG: Digoxin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina
Status: COMPLETED
Conditions: SARS-CoV-2
Interventions: DIAGNOSTIC_TEST: Serological Assay or IgG for SARS-CoV-2
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
Status: ENROLLING_BY_INVITATION
Conditions: Tobacco-Related Carcinoma|Smoking Cessation
Interventions: BEHAVIORAL: Enhanced Academic Detailing|OTHER: Informational Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Status: TERMINATED
Conditions: Chronic Lymphocytic Leukemia|Leukemia
Interventions: DRUG: 5-Azacytidine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Mental Representation Techniques for the Treatment of Parkinson´s Disease-related Pain
Status: UNKNOWN
Conditions: Parkinson Disease|Pain
Interventions: BEHAVIORAL: Action Observation+Motor Imagery through BCI|BEHAVIORAL: Action Observation through non-related with movement illustrations
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
Status: COMPLETED
Conditions: Pulmonary Hypertension
Interventions: DRUG: UT-15C SR|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients
Status: COMPLETED
Conditions: Renal Transplant Recipients
Interventions: DRUG: Tacrolimus sustained-release capsule
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral
Status: RECRUITING
Conditions: Loss of Teeth Due to Extraction|Alveolar Bone Loss|Edentulous Alveolar Ridge
Interventions: COMBINATION_PRODUCT: rhBMP-2-BBM|DEVICE: Bio-Oss+Bio-Gide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Status: COMPLETED
Conditions: Choroidal Neovascularization|Age-Related Macular Degeneration
Interventions: DRUG: ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation
Status: UNKNOWN
Conditions: Atrial Fibrillation
Interventions: OTHER: CareLink Express RM system|OTHER: Standard follow-up
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
Status: COMPLETED
Conditions: Leukemia
Interventions: OTHER: laboratory biomarker analysis|OTHER: medical chart review|OTHER: metabolic assessment|OTHER: questionnaire administration|PROCEDURE: assessment of therapy complications
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: HIS-Purkinje Conduction System Pacing Optimized Trial of Cardiac Resynchronization Therapy
Status: COMPLETED
Conditions: Heart Failure，Congestive|Cardiomyopathies|Left Ventricular Dysfunction
Interventions: DEVICE: HOT-CRT|DEVICE: Biventricular Pacing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)
Status: COMPLETED
Conditions: Graft vs Host Disease
Interventions: PROCEDURE: intra-arterial treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
Status: UNKNOWN
Conditions: Urothelial Carcinoma
Interventions: DRUG: BIBF1120
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Status: COMPLETED
Conditions: Hemodialysis|Hyperphosphatemia|Cardiovascular Events
Interventions: DRUG: Sevelamer HCl|DRUG: Calcium-based phosphate binder
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Status: TERMINATED
Conditions: Idiopathic Thrombocytopenic Purpura
Interventions: DRUG: Eltrombopag|DRUG: Avatrombopag|DRUG: Standard of care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria
Status: TERMINATED
Conditions: Carcinoma, Hepatocellular
Interventions: RADIATION: Proton Beam Radiotherapy|DRUG: Sorafenib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Transconjunctival vs Transcutaneous Anaesthesia in Oculoplastics
Status: UNKNOWN
Conditions: Anesthesia, Local|Eyelid Diseases
Interventions: DRUG: Topical Anesthetic|PROCEDURE: Transconjunctival anaesthetic|PROCEDURE: Transcutaneous anaesthetic|OTHER: Patient comfort questionnaire|OTHER: Facial photograph|PROCEDURE: Eyelid surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Status: TERMINATED
Conditions: Cryptococcal Meningitis
Interventions: BIOLOGICAL: Efungumab (Mycograb)|BIOLOGICAL: placebo|BIOLOGICAL: Amphotericin B|BIOLOGICAL: 5 flucytosine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Status: RECRUITING
Conditions: Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease|Pediatric Crohns Disease|Pediatric Ulcerative Colitis
Interventions: DIAGNOSTIC_TEST: Bowel Ultrasound Scan
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
Status: TERMINATED
Conditions: Asthma
Interventions: DRUG: Placebo|DRUG: Fluticasone propionate|DRUG: BI 54903
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants
Status: UNKNOWN
Conditions: Streptococcus Pneumoniae
Interventions: BIOLOGICAL: 7 valent pneumococcal conjugate vaccine (7v-PCV) - Prevenar
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Status: COMPLETED
Conditions: Pregnancy|HIV|AIDS
Interventions: DRUG: Norethindrone acetate
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer
Status: COMPLETED
Conditions: Gastric Cancer
Interventions: DRUG: Taxol, UFT,Leucovorin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women
Status: COMPLETED
Conditions: Alcohol Drinking|Alcohol Abuse|Alcohol; Harmful Use
Interventions: BEHAVIORAL: Personalized Normative Feedback
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients
Status: RECRUITING
Conditions: General Anesthesia|Dexmedetomidine|Ketamine|Local Infiltration|Atrial Septal Defect
Interventions: OTHER: General Anesthesia|OTHER: Local anesthesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction
Status: UNKNOWN
Conditions: Reperfused Acute Myocardial Infarction
Interventions: OTHER: Granulocite Colony Stimulating Factor treatment (G-CSF)|OTHER: Bone marrow mononuclear cells
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)
Status: RECRUITING
Conditions: Family Caregivers|Stroke
Interventions: BEHAVIORAL: Telehealth Assessment and Skill-Building Kit (TASK III) Group|BEHAVIORAL: Information Support and Referral (ISR) Group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effect of Hydrotherapy Versus Aerobic Exercise on Pulmonary Function on Hemiplegic Cerebral Palsied Children
Status: RECRUITING
Conditions: To Compare the Effectiveness of Hydrotherapy Versus Aerobic Exercise on Pulmonary Function in Hemiplegic Children With Cerebral Palsy
Interventions: OTHER: Conventional physical therapy|OTHER: Hydrotherapy|OTHER: Aerobic exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
Status: COMPLETED
Conditions: Cervical Cancer
Interventions: DRUG: cisplatin|DRUG: fluorouracil|RADIATION: brachytherapy|RADIATION: radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell Lymphoma
Status: WITHDRAWN
Conditions: Recurrent Mantle Cell Lymphoma|Refractory Mantle Cell Lymphoma
Interventions: DRUG: Eprenetapopt|DRUG: Venetoclax
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
Status: UNKNOWN
Conditions: Atherosclerosis|Cardiovascular Disease
Interventions: DRUG: Vitamins: Folic acid, B6, B12
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE|Primary Purpose: PREVENTION
Clinical trial: Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam
Status: COMPLETED
Conditions: Drug Interaction Potentiation
Interventions: DRUG: LEO 32731|DRUG: Midazolam
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Peer Debriefing Versus Instructor Debriefing for Interprofessional Simulation Based Education
Status: COMPLETED
Conditions: Crisis Resource Management
Interventions: OTHER: Peer-led debriefing|OTHER: Expert instructor debriefing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Healing Hearts and Mending Minds in Older Adults Living With HIV
Status: COMPLETED
Conditions: HIV|Cardiovascular Disease|AIDS
Interventions: BEHAVIORAL: Let's Move Program|BEHAVIORAL: Let's Flex Program|BEHAVIORAL: Group Motivational Interviewing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Status: NOT_YET_RECRUITING
Conditions: Gastric Carcinoma
Interventions: DRUG: Apatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Rehabilitation of Atrophic Jaws Using Short Implants With Different Surface Characteristics
Status: RECRUITING
Conditions: Peri-Implantation Loss|Periodontal Bone Loss|Periimplantitis|Gingival Inflammation|Implant Complication|Osseointegration Failure of Dental Implant
Interventions: DEVICE: implants placement
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia
Status: COMPLETED
Conditions: Lipoprotein Lipase Deficiency, Familial|Hyperlipoproteinemia Type I|Chylomicronemia, Familial|Hypertriglyceridemia
Interventions: DRUG: CAT-2003|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Status: COMPLETED
Conditions: Postpartum Haemorrhage
Interventions: DRUG: Fibrinogen Concentrate|DRUG: Isotonic Saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
Status: TERMINATED
Conditions: COVID-19|Lymphocytopenia
Interventions: DRUG: CYT107|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
Status: NOT_YET_RECRUITING
Conditions: Acute Graft-versus-host Disease
Interventions: PROCEDURE: Time of stem cell infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
Status: RECRUITING
Conditions: Ataxia Telangiectasia|Louis Bar Syndrome
Interventions: DRUG: IB1001
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Blood Glucose, Cognition and Wellbeing @ Work
Status: COMPLETED
Conditions: Healthy|PreDiabetes
Interventions: OTHER: Personalized feedback|OTHER: Generic feedback|DEVICE: Continuous glucose monitoring device
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women
Status: COMPLETED
Conditions: Invitro Fertilization
Interventions: PROCEDURE: Invitro fertilization
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: THRIVE Improves Early Postoperative Atelectasis in Long-Time Non-Tracheal Intubation Anesthesia for Gastrointestinal Endoscopy: A Clinical Study
Status: ACTIVE_NOT_RECRUITING
Conditions: Early Postoperative Atelectasis
Interventions: PROCEDURE: Transnasal humidified rapid insufflation ventilatory exchange（THRIVE）|PROCEDURE: conventional oxygen mask
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC)
Status: RECRUITING
Conditions: Colorectal Polyp|Colon Adenoma|Colon Cancer
Interventions: PROCEDURE: Cold Snare Endoscopic mucosal resection with adjuvant snare tip soft coagulation|PROCEDURE: Cold Snare Endoscopic Mucosal Resection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration
Status: ENROLLING_BY_INVITATION
Conditions: Acute Kidney Injury|Chronic Kidney Diseases|Renal Dialysis
Interventions: DEVICE: CARPEDIEM
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001)
Status: ACTIVE_NOT_RECRUITING
Conditions: Neoplasms
Interventions: BIOLOGICAL: MK-0482|BIOLOGICAL: pembrolizumab|DRUG: Paclitaxel|DRUG: Nab-paclitaxel|DRUG: Gemcitabine|DRUG: Carboplatin|DRUG: Pemetrexed
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Pattern Recognition Control and Direct Control in TMR
Status: COMPLETED
Conditions: Amputation|Amputation; Traumatic, Arm, Upper
Interventions: DEVICE: Commercial system|DEVICE: RIC arm system|OTHER: Direct Control|OTHER: Pattern Recognition
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: |Primary Purpose: BASIC_SCIENCE
Clinical trial: Follow-up of NAFLD Patients With MRI-PDFF
Status: COMPLETED
Conditions: Diabetes Type 2|NAFLD
Interventions: DRUG: Empagliflozin 25 MG|DRUG: Ursodeoxycholic acid|DRUG: Pentoxifylline 400 MG|OTHER: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Multi-centre Clinical Investigation to Assess the Performance of GentleCath™ Glide Intermittent Catheters
Status: COMPLETED
Conditions: Comfort and Performance of Intermittent Catheter
Interventions: DEVICE: Intermittent Catheter
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DRUG: UFT (uracil, tegafur) and tamoxifen|DRUG: CMF(cyclophosphamide, methotrexate, fluorouracil) and tamoxifen
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children
Status: COMPLETED
Conditions: Virus Diseases
Interventions: BIOLOGICAL: GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A)|BIOLOGICAL: Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Homebound Elderly People Psychotherapeutic Intervention
Status: COMPLETED
Conditions: Mild Cognitive Impairment|Depressive Symptoms|Anxiety State
Interventions: BEHAVIORAL: HEPPI
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
Status: COMPLETED
Conditions: Prostate Cancer|Cancer of Prostate|Prostatic Cancer|Cancer of the Prostate
Interventions: DRUG: YM155
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treating Refractory Schizophrenia With rTMS
Status: TERMINATED
Conditions: Schizophrenia
Interventions: DEVICE: 1 Hz rTMS|DEVICE: 10 Hz rTMS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: Sustainment
Status: COMPLETED
Conditions: Sleep Wake Disorders|Circadian Rhythm Disorders
Interventions: BEHAVIORAL: Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)|BEHAVIORAL: Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
Status: TERMINATED
Conditions: Focal Segmental Glomerulosclerosis
Interventions: DRUG: Galactose
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section
Status: COMPLETED
Conditions: Contraception
Interventions: DEVICE: Copper IUD ( ParaGard Intrauterine Contraceptive Device)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: THE EFFECT OF LIFESTYLE ON THE PROGRESS OF COVID 19
Status: UNKNOWN
Conditions: COVID-19|Lifestyle Factors
Interventions: OTHER: Mini Nutritional Assessment ,Pıtsburg Sleep Qualıty Scale, Short Physical Activity Survey
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: The Dosage Effect of pBFS Guided rTMS Treatment for MDD
Status: RECRUITING
Conditions: Moderate Depression|Major Depressive Disorder|Severe Depression
Interventions: DEVICE: 4 session rTMS|DEVICE: 6 session rTMS|DEVICE: 8 session rTMS|DEVICE: 10 session rTMS|DEVICE: sham rTMS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Male Stress Urinary Incontinence and Sexual Health
Status: WITHDRAWN
Conditions: Prostate Cancer
Interventions: DEVICE: Artificial urinary sphincter|DEVICE: InVance Sling|DEVICE: AdVance Sling|DEVICE: Virtue Sling|DRUG: Contigen
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients
Status: COMPLETED
Conditions: Transfusion-dependent Beta-Thalassemia
Interventions: DRUG: Thalidomide
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia
Status: RECRUITING
Conditions: Breast Cancer|Mastectomy|Pain, Chronic|Pain, Post Operative
Interventions: PROCEDURE: Opioid-free anesthesia|PROCEDURE: Conventional opioid-based anesthesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases
Status: WITHDRAWN
Conditions: Hereditary Diseases|Cholestasis, Intrahepatic
Interventions: DRUG: 4-Phenylbutyrate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: iBCI Optimization for Veterans With Paralysis
Status: NOT_YET_RECRUITING
Conditions: Spinal Cord Injury|Amyotrophic Lateral Sclerosis|Brain Stem Infarctions|Locked-in Syndrome|Muscular Dystrophy
Interventions: DEVICE: Mobile neural decoding platform (mobile iBCI)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
Status: TERMINATED
Conditions: Multiple Sclerosis
Interventions: OTHER: pet-scan FDG-F18
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Find Out How Symptoms Severity Changes During the Standard Course of Treatment With the Cream Relief Pro and Suppositories Relief Pro (Active Ingredients Are Fluocortolone + Lidocaine) in Patients Suffering From Twisted and Bulging Veins in the Rectal Area (Acute Hemorrhoids)
Status: COMPLETED
Conditions: Acute Hemorrhoids
Interventions: DRUG: Relief Pro cream|DRUG: Relief Pro rectal suppositories
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p